In-vitro fertilization is a laborious process that requires careful preparation and incubation of embryos. INVO Bioscience out of Medford, Massachusetts just received FDA de novo approval to introduce its INVOcell intravaginal culture system that allows women to use their bodies as the incubator.
Incubators have to control all sorts of parameters, such as temperature, oxygenation, and CO2, to make sure embryos are growing up in a healthy environment. The INVOcell instead provides housing for fertilized eggs which is placed within the vagina, letting the mother’s own body act as a natural incubating environment, something it has nearly perfectly evolved to perform.
The technology purportedly leads to fewer twins while reducing unused embryos, and since an incubator with the accompanying staff is not required the cost of IVF treatment should be lower.
In Europe the INVOcell has had approval since 2008.
Source: INVO Bioscience…